Biosimilars: A Fancy Name for Generics But Oh So Much More Disastrous

Sep 07, 2007

Over on VentureBeat, David Hamilton writes that even normally smart biotechnology investors get a little dim when talking about biosimilars and the loss of patent protection for biotech drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test
Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization
Fauna Bio Gets $373K NIH Grant to Study Animal Genomes for Potential Drug Targets
New Products Posted to GenomeWeb: Purigen Biosystems, Zymo Research, Qiagen, More
People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More
In Brief This Week: Invenio Genetics, Swift Biosciences, Caris Life Sciences, and More

The Scan

Letter Urges New Inquiry

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

Great Apes Get Shots, Too

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Woodcock on Vaccines, More

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

Science Paper Examines Molecular Contributors to Kidney Fibrosis

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.

Menu